首页> 外文期刊>Journal of Medicinal Chemistry >Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.
【24h】

Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.

机译:碳酸酐酶抑制剂:通过局部途径合成具有持久眼内降压性能的水溶性氨酰基/二肽基磺酰胺。

获取原文
获取原文并翻译 | 示例
           

摘要

Reaction of 26 aromatic/heterocyclic sulfonamides containing amino, imino, hydrazino, or hydroxyl groups with Boc-Gly, Boc-Sar, TrS-Crt, or Boc-Gly-Gly (Sar = sarcosine, N-Me-Gly; Crt = creatine, N-amidinosarcosine; TrS = tritylsulfenyl; Boc = tert-butoxycarbonyl) in the presence of carbodiimide derivatives afforded after removal of the protecting groups a series of water-soluble compounds (as salts of strong acids, such as hydrochloric, trifluoroacetic, or trifluoromethanesulfonic). The new derivatives were assayed as inhibitors of the zinc enzyme carbonic anhydrase (CA) and more precisely of three of its isozymes, CA I, II (cytosolic forms), and IV (membrane-bound form), involved in important physiological processes. Efficient inhibition was observed against all three isozymes and especially against CA II and IV (in the nanomolar range), the two isozymes known to play a critical role in aqueous humor secretion within the ciliary processes of the eye. Some of the best inhibitors synthesized were applied as 2% water solutions into the eye of normotensive or glaucomatous albino rabbits, when strong and long-lasting intraocular pressure (IOP) lowering was observed with many of them. Thus, the aminoacyl/dipeptidyl tail conferring water solubility to these sulfonamide CA inhibitors coupled with strong enzyme inhibitory properties and balanced lipid solubility seem to be the key factors for obtaining compounds with effective topical antiglaucoma activity.
机译:26种含氨基,亚氨基,肼基或羟基的芳香族/杂环磺酰胺与Boc-Gly,Boc-Sar,TrS-Crt或Boc-Gly-Gly(Sar =肌氨酸,N-Me-Gly; Crt =肌酸,N-ami肌氨酸; TrS =三苯磺酰基; Boc =叔丁氧基羰基),在存在碳二亚胺衍生物的情况下,除去保护基团后得到了一系列水溶性化合物(作为强酸的盐,如盐酸,三氟乙酸或三氟甲磺酸) )。分析了新衍生物作为锌酶碳酸酐酶(CA)的抑制剂,更确切地说,是涉及重要生理过程的三种同工酶CA I,II(胞质形式)和IV(膜结合形式)的抑制剂。观察到有效抑制所有三种同工酶,尤其是针对CA II和IV(在纳摩尔范围内),这两种同工酶已知在眼睛睫状突中房水分泌中起关键作用。当观察到许多强抑制剂和持久性降低眼内压(IOP)时,一些合成的最佳抑制剂以2%水溶液的形式应用于正常血压或青光眼性白化病兔子的眼睛。因此,赋予这些磺酰胺CA抑制剂水溶性的氨酰基/二肽基尾巴,加上强大的酶抑制性能和平衡的脂质溶解性,似乎是获得具有有效局部抗青光眼活性的化合物的关键因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号